Skip to content
PeptideAgent

Telehealth providers in Pennsylvania

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in Pennsylvania, including asynchronous care. What Pennsylvania requires of telehealth prescribers and pharmacies, plus verified listings.

Pennsylvania at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving Pennsylvania

No verified telehealth providers serving Pennsylvania are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in Pennsylvania

Act 42 of 2024 (Senate Bill 739, signed July 2024) is Pennsylvania's first comprehensive telemedicine statute. It defines telemedicine to include synchronous and asynchronous (store-and-forward) technology, authorizes any Pennsylvania-licensed health care practitioner to provide telemedicine within the practitioner's scope of practice, requires the same standard of care as in-person practice, and requires insurers to cover telemedicine services. The Act allows a practitioner to prescribe from a telemedicine encounter, subject to the practitioner's licensing board regulations and federal law on controlled substances. Before Act 42, Pennsylvania had no telemedicine statute and boards relied on general practice standards. The prescriber must hold a Pennsylvania license (or an Interstate Medical Licensure Compact license issued through the Pennsylvania State Board of Medicine). None of the peptides in this database are controlled substances, so no additional in-person requirement applies. [2] [3] [10]

Compounded GLP-1 access in Pennsylvania

Telehealth GLP-1 patients should confirm the dispensing pharmacy holds a Pennsylvania pharmacy permit or nonresident pharmacy registration. [1] [8]

Research use only sellers in Pennsylvania

The Pennsylvania Pharmacy Act restricts dispensing of prescription drugs to licensed pharmacies, and the Controlled Substance, Drug, Device and Cosmetic Act (35 P.S. section 780-101 and following) prohibits the sale of adulterated, misbranded, or unapproved new drugs in the Commonwealth. [4] [6] [9]

How to check a telehealth provider in Pennsylvania

  1. Confirm the prescriber is licensed or registered to treat patients located in Pennsylvania; the telehealth rules above explain what Pennsylvania requires. [2] [3] [10]
  2. Ask which pharmacy will fill the prescription and check it in the Pennsylvania State Board of Pharmacy (Department of State, Bureau of Professional and Occupational Affairs) license lookup. [1] [4] [5] [7]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Pennsylvania. [4] [6] [9]

Common questions in Pennsylvania

Can an out-of-state pharmacy ship compounded peptides to me in Pennsylvania?

Only if it holds a certificate of registration from the Pennsylvania State Board of Pharmacy as a nonresident pharmacy. Section 4.1 of the Pharmacy Act (63 P.S. section 390-4.1) bars a nonresident pharmacy from shipping legend drugs into Pennsylvania without one. Search the Department of State license verification for the pharmacy name; if it is not registered, the shipment is not lawful in Pennsylvania even if the prescriber is compliant. [1] [4]

All peptide legal questions for Pennsylvania

Sources

  1. [1]Pennsylvania State Board of Pharmacy
  2. [2]Pennsylvania Act 42 of 2024 (Senate Bill 739), telemedicine
  3. [3]Pennsylvania State Board of Medicine (licensure and Interstate Medical Licensure Compact)
  4. [4]Pennsylvania Pharmacy Act, Act of Sept. 27, 1961, P.L. 1700, No. 699 (63 P.S. section 390-1 and following), including section 4.1, Nonresident pharmacies
  5. [5]49 Pa. Code chapter 27, State Board of Pharmacy regulations (compounding, sections 27.601 to 27.606)
  6. [6]Pennsylvania Controlled Substance, Drug, Device and Cosmetic Act, 35 P.S. section 780-101 and following (Act 1972-64)
  7. [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  8. [8]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  9. [9]21 U.S.C. 331, Prohibited acts
  10. [10]Interstate Medical Licensure Compact Commission: participating states